Why Abeona Therapeutics Inc Stock Jumped Higher Today
Shares of Abeona Therapeutics (NASDAQ: ABEO) are up 18% as of 2:50 p.m. EDT after an analyst from RBC Capital initiated coverage of the gene therapy company with an outperform rating and assigned a $23 price target, more than 35% higher than it is right now.
Abeona Therapeutics has been on fire lately, up more than 250% over the last six months, but much of the higher stock price has come from increasing positive investor sentiment off of a fairly low market cap rather than any fundamental change in Abeona's valuation.
Image source: Getty Images.
Source: Fool.com
Abeona Therapeutics Inc. Stock
€4.00
2.560%
Currently there is a rather positive sentiment for Abeona Therapeutics Inc. with 3 Buy predictions and 1 Sell predictions.
With a target price of 34 € there is potential for a 750.0% increase which would mean more than doubling the current price of 4.0 € for Abeona Therapeutics Inc..
